Furthermore, in the ex vivo breast cancer tissue assay, the size of cancer tissue fragments, freshly isolated from a patient with breast cancer, was significantly reduced in 3 days by the application of Oct4 CM and OAC2-treated CM (Figure 1H). This evidence concerns the gene POU5F1 and cancer.